WHO ICTRP trial
A phase II study comparing carboplatin plus pemetrexed followed by maintenance…
JPRN-UMIN000013387 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000013387 |
|---|---|
| Public title | A phase II study comparing carboplatin plus pemetrexed followed by maintenance pemetrexed with pemetrexed in elderly patients with advanced epidermal growth factor receptor non-squamous non-small-cell lung cancer (LCEN1301) |
| Scientific title | A phase II study comparing carboplatin plus pemetrexed followed by maintenance pemetrexed with pemetrexed in elderly patients with advanced epidermal growth factor receptor non-squamous non-small-cell lung cancer (LCEN1301) - A phase II study comparing CBDCA plus PEM followed by maintenance PEM with… |
| Primary sponsor | Lung Cancer Experts Network (LCEN) |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase II |
| Countries | Japan |
| Conditions | Elderly patients with advanced non-squamous non-small-cell lung cance |
| Interventions | A: Pemetrexed (500mg/m2) given on day 1 every 3 weeks B: Carboplatin (AUC 5) plus pemetrexed (500 mg/m2) given on day 1 every 3 weeks. If the patients do not develop disease progression, continuation maintenance of pemetrexed (500 mg/m2) is… |
| Registration date | Nov 3, 2014 |
| Target size | 76 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: